A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease
SMART: Stress Echocardiography in Menopausal Women at Risk for Coronary Artery Disease Trial
Sponsor: Lantheus Medical Imaging
A PHASE4 clinical study on Coronary Artery Disease and Heart Disease, this trial is completed. The trial is conducted by Lantheus Medical Imaging and has accumulated 10 data snapshots since 2004. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Study Description(click to expand)The clinical trial is designed to determine the prognostic value of stress echocardiography as a screening examination in peri-, or post-menopausal female patients with an intermediate likelihood of coronary artery disease (CAD) based on risk factors to identify patients at higher risk of experiencing future cardiac events.Female patients who are able to adequately exercise will undergo a symptom-limited exercise echocardiogram. Patients who are unable to adequately exercise or are predicted to be unable to exercise adequately (because of orthopedic/neurologic limitations, lung disease or debility), will perform dobutamine stress echocardiography. All patients will receive DEFINITY at rest and stress to enhance wall motion assessment.
The clinical trial is designed to determine the prognostic value of stress echocardiography as a screening examination in peri-, or post-menopausal female patients with an intermediate likelihood of coronary artery disease (CAD) based on risk factors to identify patients at higher risk of experiencing future cardiac events.Female patients who are able to adequately exercise will undergo a symptom-limited exercise echocardiogram. Patients who are unable to adequately exercise or are predicted to be unable to exercise adequately (because of orthopedic/neurologic limitations, lung disease or debility), will perform dobutamine stress echocardiography. All patients will receive DEFINITY at rest and stress to enhance wall motion assessment.
Status Flow
Change History
10 versions recorded-
Jan 2026 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Mar 2022 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2022 — Mar 2022 [monthly]
Completed PHASE4
▶ Show 5 earlier versions
-
Apr 2021 — Jan 2022 [monthly]
Completed PHASE4
-
Jan 2021 — Apr 2021 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE4
First recorded
Apr 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Lantheus Medical Imaging
For direct contact, visit the study record on ClinicalTrials.gov .